March 13, 2019
Tatiana Karelina, Head of the Alzheimer’s Disease modeling group at InSysBio participated in the Russian TV show «Us and science. Science and us». The theme of the show was Alzheimer’s Disease (AD) and the guests were experts, such a gerontopsychiatrist, a neurologist and a biochemist, representing either optimistic or skeptical positions. Tatiana presented an optimistic point of view and told about AD causes, risk factors, pathological mechanisms and future therapeutic approaches. The video is available on the NTV channel website.
“We are just beginning to research the potential therapies. AD is a multifactorial process, so the potential therapy will be not, for example, an amyloid-targeted particular drug, but it will be a particular combination of such particular drugs. There are many AD triggers, and diverse factors contribute to its pathogenesis, but results are the same: amyloid plaques and neurofibrillary tangles formation and neuron loss. The future treatment will be preventive as well as personalized, so there will be expected many clinical trials investigating various combinatorial therapies,” introduced Tatiana Karelina.
About InSysBio
InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative approach has already become a part of the drug development process implemented by our strategic partners: nowadays there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. The company has published multiple scientific studies in various therapeutic areas. InSysBio team is developing software and tools for QSP and continuously improves methods for biological modeling. For more information about InSysBio, its solutions and services, visit insysbio.com.
| ← | April 2022 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
|
2
|
3
| ||||
|
4
1.
04 Apr 2022 11:02
InSysBio to participate in Quantitative Systems Pharmacology for Immuno-Oncology
InSysBio announces its participation in Quantitative Systems Pharmacology for Immuno-Oncology, a joint meeting of the EMBL's European Bioinformatics Institute (EMBL-EBI) & the UK QSP Network which is to be held 25th & 26th April 2022 in person at the EMBL-EBI Main Building, Hinxton, Cambridgeshire, UK
|
5
|
6
|
7
|
8
|
9
|
10
|
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
|
25
1.
25 Apr 2022 17:43
InSysBio's ASCPT 2022 Micro-Theater Session on YouTube
InSysBio has published the videos of its presentation in frames of Micro-Theater Session at ASCPT 2022 Annual Meeting on InSysBio YouTube channel. Oleg Demin and Alexander Stepanov covered the topic of Online databases collecting and processing publicly available data that can help in calibration and validation of QSP models.
|
26
|
27
|
28
|
29
|
30
| |
Thank you for your message! We will get back to you shortly.
